These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34455462)

  • 1. Impact of HAS-BLED Score on outcome after percutaneous left atrial appendage closure: insights from the German Left Atrial Appendage Occluder Registry LAARGE.
    Ledwoch J; Franke J; Brachmann J; Lewalter T; Akin I; Senges J; Hochadel M; Zeymer U; Weiß C; Krapivsky A; Sievert H
    Clin Res Cardiol; 2022 May; 111(5):541-547. PubMed ID: 34455462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II.
    López-Mínguez JR; Nogales-Asensio JM; Infante De Oliveira E; De Gama Ribeiro V; Ruiz-Salmerón R; Arzamendi-Aizpurua D; Costa M; Gutiérrez-García H; Fernández-Díaz JA; Martín-Yuste V; Rama-Merchán JC; Moreno-Gómez R; Benedicto-Buendía A; Íñiguez-Romo A
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):449-455. PubMed ID: 29754808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial appendage closure in patients with a reduced left ventricular ejection fraction: results from the multicenter German LAARGE registry.
    Fastner C; Brachmann J; Lewalter T; Zeymer U; Sievert H; Borggrefe M; Weiß C; Geist V; Krapivsky A; Käunicke M; Mudra H; Hochadel M; Schneider S; Senges J; Akin I
    Clin Res Cardiol; 2020 Nov; 109(11):1333-1341. PubMed ID: 32236717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison in Patients < 75 Years of Age - Versus - Those > 75 Years on One-year-Events With Atrial Fibrillation and Left Atrial Appendage Occluder (From the Prospective Multicenter German LAARGE Registry).
    Nasasra AE; Brachmann J; Lewalter T; Akin I; Sievert H; Nienaber CA; Weiß C; Pleger ST; Ince H; Maier J; Achenbach S; Sigusch HH; Hochadel M; Schneider S; Senges J; Zeymer U
    Am J Cardiol; 2020 Dec; 136():81-86. PubMed ID: 32946860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation versus antiplatelet therapy after percutaneous left atrial appendage closure-subanalysis from the multicenter LAARGE registry.
    Ledwoch J; Staubach S; Akin I; Ince H; Zeymer U; Pleger S; Sievert H; Hochadel M; Senges J; Lewalter T; Brachmann J; Mudra H
    J Interv Card Electrophysiol; 2022 Aug; 64(2):489-496. PubMed ID: 34686928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventional occlusion of left atrial appendage in patients with atrial fibrillation. Acute and long-term outcome of occluder implantation in the LAARGE Registry.
    Brachmann J; Lewalter T; Akin I; Sievert H; Geist V; Zeymer U; Erkapic D; Mudra H; Pleger S; Hochadel M; Senges J
    J Interv Card Electrophysiol; 2020 Sep; 58(3):273-280. PubMed ID: 31707534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial appendage closure in patients with chronic kidney disease: results from the German multicentre LAARGE registry.
    Fastner C; Brachmann J; Lewalter T; Zeymer U; Sievert H; Borggrefe M; Nienaber CA; Weiß C; Pleger ST; Ince H; Maier J; Achenbach S; Sigusch HH; Hochadel M; Schneider S; Senges J; Akin I
    Clin Res Cardiol; 2021 Jan; 110(1):12-20. PubMed ID: 32296971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of atrial fibrillation pattern on outcomes after left atrial appendage closure: lessons from the prospective LAARGE registry.
    Kany S; Brachmann J; Lewalter T; Akin I; Sievert H; Zeymer U; Ledwoch J; Ince H; Thomas D; Hochadel M; Senges J; Kirchhof P; Rillig A
    Clin Res Cardiol; 2022 May; 111(5):511-521. PubMed ID: 34043052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of left atrial appendage closure in non-valvular atrial fibrillation in patients over 75 years.
    Yu J; Chen H; Post F; Muenzel M; Keil T; Hou CR; Zhao M; Meng Z; Jiang L
    Heart Vessels; 2019 Nov; 34(11):1858-1865. PubMed ID: 31144099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventional occlusion of left atrial appendage in patients with atrial fibrillation. Gender-related outcomes in the German LAARGE Registry.
    Kleinecke C; Lewalter T; Sievert H; Geist V; Zeymer U; Mudra H; Pleger S; Hochadel M; Senges J; Brachmann J
    J Cardiovasc Electrophysiol; 2021 Oct; 32(10):2636-2644. PubMed ID: 34314065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
    Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
    Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage closure for stroke prevention in atrial fibrillation: Final report from the French left atrial appendage closure registry.
    Teiger E; Thambo JB; Defaye P; Hermida JS; Abbey S; Klug D; Juliard JM; Spaulding C; Armero S; Champagnac D; Bhugaloo H; Ternacle J; Lellouche N; Audureau E; Le Corvoisier P;
    Catheter Cardiovasc Interv; 2021 Oct; 98(4):788-799. PubMed ID: 34051135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is spontaneous echo contrast associated with device-related thrombus or embolic events after left atrial appendage occlusion? - Insights from the multicenter German LAARGE registry.
    Fastner C; Müller C; Brachmann J; Lewalter T; Akin I; Sievert H; Käunicke M; Zeymer U; Hochadel M; Schneider S; Senges J; Erkapic D; Weiß C
    J Interv Card Electrophysiol; 2024 Jan; 67(1):119-128. PubMed ID: 37261553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.
    Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z
    Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry.
    Kefer J; Vermeersch P; Budts W; Depotter T; Aminian A; Benit E; Stammen F
    Acta Cardiol; 2013 Dec; 68(6):551-8. PubMed ID: 24579432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
    Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
    Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stand-Alone Thoracoscopic Left Atrial Appendage Closure in Nonvalvular Atrial Fibrillation Patients at High Bleeding Risk.
    Franciulli M; De Martino G; Librera M; Desoky A; Mariniello A; Iavazzo A; Scigliano F; Esposito G; Chiariello L
    Innovations (Phila); 2020; 15(6):541-546. PubMed ID: 33048625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.